Omarigliptin decreases inflammation and insulin resistance in a pleiotropic manner in patients with type 2 diabetes

by Sachiko Hattori
Published 2020-03-01

Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance

by Sachiko Hattori
Published 2018-12-01

Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis

by Sachiko Hattori, Kazuomi Nomoto, Tomohiko Suzuki, Seishu Hayashi
Published 2021-03-01